Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2017 Mar;139(3):733–742. doi: 10.1016/j.jaci.2017.01.005

Figure 3.

Figure 3

Evaluation and management of non-SCID T cell lymphopenia (persistently <1500 CD3 T cells); continued follow-up is needed to determine degree and persistence of immune impairment, whether prophylactic therapy is needed, and whether an underlying etiology can be found.

*Variable can be <200 naïve CD4 T cells